J 2016

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: Enrichment in subset 2 is associated with markedly short telomeres

NAVRKALOVÁ, Veronika; Emma YOUNG; Panagiotis BALIAKAS; Lenka RADOVÁ; Lesley-Ann SUTTON et. al.

Basic information

Original name

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: Enrichment in subset 2 is associated with markedly short telomeres

Name in Czech

Mutace ATM v hlavních stereotypních podskupinách chronické lymfocytární leukémie: obohacení v podskupině 2 je spojeno s výrazně krátkými telomery

Authors

NAVRKALOVÁ, Veronika (203 Czech Republic, belonging to the institution); Emma YOUNG (752 Sweden); Panagiotis BALIAKAS (752 Sweden); Lenka RADOVÁ (203 Czech Republic, belonging to the institution); Lesley-Ann SUTTON (752 Sweden); Karla PLEVOVÁ (203 Czech Republic, belonging to the institution); Larry MANSOURI (752 Sweden); Viktor LJUNGSTRÖM (752 Sweden); Stavroula NTOUFA (300 Greece); Zadie DAVIS (826 United Kingdom of Great Britain and Northern Ireland); Gunnar JULIUSSON (752 Sweden); Karin E. SMEDBY (752 Sweden); Chrysoula BELESSI (300 Greece); Panagiotis PANAGIOTIDIS (300 Greece); Tasoula TOULOUMENIDOU (300 Greece); Frederic DAVI (250 France); Anton W. LANGERAK (528 Netherlands); Paolo GHIA (380 Italy); Jonathan C. STREFFORD (826 United Kingdom of Great Britain and Northern Ireland); David OSCIER (826 United Kingdom of Great Britain and Northern Ireland); Jiří MAYER (203 Czech Republic, belonging to the institution); Kostas STAMATOPOULOS (300 Greece); Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution); Richard ROSENQUIST (752 Sweden) and Martin TRBUŠEK (203 Czech Republic, guarantor, belonging to the institution)

Edition

Haematologica, Pavia, Ferrata Storti Foundation, 2016, 0390-6078

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30204 Oncology

Country of publisher

Italy

Confidentiality degree

is not subject to a state or trade secret

Impact factor

Impact factor: 7.702

RIV identification code

RIV/00216224:14110/16:00087635

Organization unit

Faculty of Medicine

UT WoS

000392547200020

EID Scopus

2-s2.0-84986222791

Keywords in English

Antigenic selection; Atm mutation; Chronic lymphocytic leukemia; Short telomere; Stereotyped subset

Tags

International impact, Reviewed
Changed: 1/11/2019 14:35, Mgr. Michal Petr

Abstract

V originále

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset 2 is associated with markedly short telomeres, ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset 2 is associated with markedly short telomeres, ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset 2 is associated with markedly short telomeres.

In Czech

Mutace ATM v hlavních stereotypních podskupinách chronické lymfocytární leukémie: obohacení v podskupině 2 je spojeno s výrazně krátkými telomery, Mutace ATM v hlavních stereotypních podskupinách chronické lymfocytární leukémie: obohacení v podskupině 2 je spojeno s výrazně krátkými telomery, Mutace ATM v hlavních stereotypních podskupinách chronické lymfocytární leukémie: obohacení v podskupině 2 je spojeno s výrazně krátkými telomery.

Links

EE2.3.30.0009, research and development project
Name: Zaměstnáním čerstvých absolventů doktorského studia k vědecké excelenci
LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NT13493, research and development project
Name: Molekulární charakterizace B buněčných receptorů a jejich vztah k evoluci genetických změn u chronické lymfocytární leukémie
TE02000058, research and development project
Name: Centrum kompetence pro molekulární diagnostiku a personalizovanou medicínu (Acronym: MOLDIMED)
Investor: Technology Agency of the Czech Republic
692298, interní kód MU
Name: MEDGENET - Medical genomics and epigenomics network (Acronym: MEDGENET)
Investor: European Union, Spreading excellence and widening participation

Files attached